These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 13910885)

  • 1. [Cardiac catecholamines after ligation of the coronary artery. Influence of a monoaminoxidase inhibitor (nialamide) on the infarct].
    SERRANO PA; VILLANUEVA SA; LERDO DE TEJADAHAY A; CASTANEDA Y; CHAVEZ LARA B; BISTENI A
    Arch Inst Cardiol Mex; 1961; 31():197-204. PubMed ID: 13910885
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of monoamine oxidase A increases recovery after experimental cardiac arrest.
    Vuohelainen V; Hämäläinen M; Paavonen T; Karlsson S; Moilanen E; Mennander A
    Interact Cardiovasc Thorac Surg; 2015 Oct; 21(4):441-9. PubMed ID: 26116370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Apropos of the mechanism of action of monoamine oxidase-inhibitors on the coronary circulation].
    Mirzoian RS
    Farmakol Toksikol; 1965; 28(1):51-5. PubMed ID: 5845043
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action of a monoamine oxidase inhibitor (Niamid) on various experimental vascular lesions in the rabbit (allergic arteritis, myocardial necrosis caused by isoproterenol, aortic medionecrosis, venous and arterial thrombosis)].
    FABRE J; RUDHARDT M; MICHEL B; LACOURT G; JEANDET J
    Chemotherapia (Basel); 1962; 4():237-47. PubMed ID: 13891221
    [No Abstract]   [Full Text] [Related]  

  • 5. Histopathological studies on the myocardial infarction in Indian domestic pigs (Sus scrofa) after coronary occlusion and the effect of some drugs affecting amine metabolism in the heart.
    Ramaswamy AS; Tatta KR; Arora RB
    Indian J Chest Dis; 1968 Apr; 10(2):1-10. PubMed ID: 5761031
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacologic characteristics of monoamine oxidase inhibitors: problems related to their use in the treatment of angina].
    Simon P
    Therapie; 1970; 25(2):343-8. PubMed ID: 5526213
    [No Abstract]   [Full Text] [Related]  

  • 7. Species differences in the cardiac effects of a monoamine oxidase inhibitor.
    GOLDBERG ND; SHIDEMAN FE
    J Pharmacol Exp Ther; 1962 May; 136():142-51. PubMed ID: 13899710
    [No Abstract]   [Full Text] [Related]  

  • 8. Antithrombotic effect of monamine oxidase inhibitor (nialamide).
    SHIMAMOTO T; ISHIOKA T; FUJITA T
    Circ Res; 1962 Apr; 10():647-57. PubMed ID: 13911935
    [No Abstract]   [Full Text] [Related]  

  • 9. [The action of 2-amino-4-(isothioureyl methyl)-thiazol dihydrochloride (Agr 307) on the catecholamines of the central nervous system in the rat. Possible inhibition of dopamine beta-hydroxylase].
    Brunaud M; Vallée E; Laborit H
    Agressologie; 1971; 12(2):113-8. PubMed ID: 5123844
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical-experimental studies on the indications and action of 1-(2-benzylcarbamylethyl)-2-isonicotinoyhydrazine (Nialamide)].
    KNICK B
    Arzneimittelforschung; 1961 Sep; 11():843-7. PubMed ID: 14457227
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and experimental data on the neurohumoral vascular and tissue effects of nialamide in cardiovascular and metabolic diseases].
    KNICK B
    Chemotherapia (Basel); 1962; 4():297-303. PubMed ID: 14457226
    [No Abstract]   [Full Text] [Related]  

  • 12. [ACTION OF A MONOAMINE OXIDASE INHIBITOR ON AMMONIEMIA DUE TO INTESTINAL INFARCT (EXPERIMENTAL RESEARCH)].
    RIGAMONTI PP; ZECCA C; MOLINAROLI P
    Minerva Anestesiol; 1965 Jan; 31():6-10. PubMed ID: 14290510
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of monoamine oxidase inhibitors on the content of catecholamines in different parts of the brain in cats].
    Vysotskaia NB; Kaverina NV; Mirzoian RS; Rozonov IuB
    Farmakol Toksikol; 1967; 30(3):289-92. PubMed ID: 5597732
    [No Abstract]   [Full Text] [Related]  

  • 14. A further contribution to the study of catecholamine flow in amphibian nerves.
    Rodríguez Echandía EL; Donoso AO; Pedroza E
    Acta Physiol Lat Am; 1972; 22(3):161-5. PubMed ID: 4120175
    [No Abstract]   [Full Text] [Related]  

  • 15. [Peripheral circulatory effect of "Niamid"].
    SCHELLING JL
    Chemotherapia (Basel); 1962; 4():112-8. PubMed ID: 14498199
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental study of pharmacological properties of nialamide].
    Gilev AP; Terekhina AI; Tarasova EI; Khavronina ZP
    Farmakol Toksikol; 1967; 30(3):328-31. PubMed ID: 4386187
    [No Abstract]   [Full Text] [Related]  

  • 17. [Influence of three I.M.A.O. on pentetrazolic shock in the rabbit].
    Allain P; Eben-Moussi E; Van den Driessche J
    Therapie; 1967; 22(2):361-6. PubMed ID: 6063423
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effectiveness and mode of action of nialamide in peripheral, arterial circulatory disorders].
    HUPKA K; THALER H
    Chemotherapia (Basel); 1962; 4():102-11. PubMed ID: 14450094
    [No Abstract]   [Full Text] [Related]  

  • 19. EFFECT OF VARIOUS MONOAMINE OXIDASE INHIBITORS ON THE CATECHOLAMINE CONTENT OF RAT HEART.
    BHAGAT B
    Arch Int Pharmacodyn Ther; 1963 Nov; 146():65-72. PubMed ID: 14078525
    [No Abstract]   [Full Text] [Related]  

  • 20. The action of nialamide on the concentration of catechol amines in heart and brain stem.
    MUSCHOLL E
    Med Esp; 1959; 1():363-7. PubMed ID: 14425478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.